MedtronicXSWX:MDT +1.21%21 Days Payable is 70.07 as of Apr. 2026, which is 6% below its 10-year median of 74.66. GuruFocus rates XSWX:MDT with a GF Score™ of 21/100 and a GF Value™ of CHF80.97 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Medtronic ranks better than 53.58% on this metric.
Medtronic's average Accounts Payable for the
three
months ended in Apr. 2026 was CHF2,055 Mil. Medtronic's Cost of Goods Sold for the
three
months ended in Apr. 2026 was CHF2,676 Mil.
Hence, Medtronic's Days Payable for the
three
months ended in Apr. 2026 was 70.07.
The historical rank and industry rank for Medtronic's Days Payable or its related term are showing as below:
XSWX:MDT'
s Days Payable Range Over the Past 10 Years
Min: 64.07 Med: 74.66 Max: 84.07
Current: 73.44
During the past 13 years, Medtronic's highest Days Payable was 84.07. The lowest was 64.07. And the median was 74.66.
XSWX:MDT's Days Payable is ranked better than 53.58% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs XSWX:MDT: 73.44
Medtronic's Days Payable
declined
from Apr. 2025 (71.66) to Apr. 2026 (70.07).
It may suggest that Medtronicaccelerated paying its suppliers.
Medtronic Days Payable Related Terms
Medtronic Days Payable Historical Data
* Premium members only.
The historical data trend for Medtronic's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medtronic's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medtronic Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Days Payable distribution charts can be found below:
* The bar in red indicates where Medtronic's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medtronic's Days Payable for the fiscal year that ended in Apr. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medtronic (XSWX:MDT) has a Days Payable of 70.07 as of Apr. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medtronic and its competitors. This is near median its historical median of 74.66. Over the past decade, Medtronic's Days Payable has ranged from 64.07 to 84.07. According to the industry distribution chart, Medtronic ranks #369 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 46.4%.
Is Medtronic's Days Payable too high?
Medtronic's current Days Payable of 70.07 is near median its 10-year median of 74.66. Over the past 10 years, this metric has ranged from a low of 64.07 to a high of 84.07. The Medical Devices & Instruments industry median Days Payable is 67.87. Medtronic's value of 70.07 is 3.2% above this industry median. Based on the distribution chart, Medtronic ranks #369 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medtronic has a GF Score™ of 21/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Days Payable compare to SYK and BSX?
According to the Medical Devices & Instruments industry distribution chart, Medtronic ranks #369 out of 795 companies for Days Payable. This puts Medtronic in the upper half of its industry. The industry median Days Payable is 67.87. Medtronic's value of 70.07 is 3.2% above this benchmark. Historically, Medtronic's own Days Payable has ranged from 64.07 to 84.07 over the past decade. While the company's 10-year median is 74.66 vs. the industry median of 67.87, Medtronic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medtronic's current Days Payable of 70.07 is 3.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medtronic and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medtronic's current Days Payable is 70.07, which is near median its own 10-year median of 74.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (XSWX:MDT) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF80.97, compared to a current price of CHF65.29 — trading 19.4% below its estimated fair value. The current Days Payable is 70.07, which is near median its 10-year median of 74.66 and 3.2% above the Medical Devices & Instruments industry median of 67.87. Medtronic's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medtronic (XSWX:MDT), the current Days Payable is 70.07 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medtronic (XSWX:MDT) Overvalued in 2026?
Based on GuruFocus' analysis, Medtronic stock appears to be undervalued.
The current stock price of CHF65.29 is trading 19.4% below its estimated GF Value™ of CHF80.97.
GuruFocus considers Medtronic to be Modestly Undervalued.
Key valuation signals for XSWX:MDT:
Days Payable: 70.07 (near median its 10-year median of 74.66)
GF Value™: CHF80.97 vs. price of CHF65.29 (19.4% below fair value)
Industry Position: 3.2% above the Medical Devices & Instruments median (#369 of 795)
No single metric tells the full story. See the XSWX:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
21GF Score
Get the complete analysis for XSWX:MDT
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MDT has been successfully added to your 
